Skip to main content
OpenTrials
Completed

NCT Number: NCT01602042

Adaptive Portable Essential Tremor Monitor

The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Rush University Medical Center, Chicago, Illinois, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years or older
  • Clinical diagnosis of essential tremor
  • Able to provide informed consent

Exclusion criteria

  • Significant medical or psychiatric illness
  • Not capable of following the required clinical instructions
  • Serious medical conditions that compromise safety

Treatment and study plan

Primary outcomes

  1. Tremor ratings during activities of daily living versus standardized tasks.

    Time frame: 10 hours each day the sensor is worn.

Sponsors and collaborators

Lead sponsor

Great Lakes NeuroTechnologies Inc.

Industry

Collaborators

  • Baylor College of Medicine
  • National Institute on Aging (NIA)
  • Rush University Medical Center

Registry information

Official study title

Phase II Study: Adaptive Portable Essential Tremor Monitor

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
May 18, 2012
Registry last updated
Dec 4, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.